Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)May 31, 2025 | (Q1)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -79.01%511K | -26.36%338K | 1.79%3.86M | 560K | 35.78%869K | 2.44M | 459K | -75.96%3.8M | -17.74%640K | -95.64%582K |
| Cost of revenue | -85.08%347K | -70.25%216K | -35.76%5.38M | 853K | 148.25%2.2M | 2.33M | 726K | -50.01%8.37M | -9.69%885K | -93.45%889K |
| Gross profit | 50.46%164K | 145.69%122K | 66.94%-1.51M | -293K | -442.04%-1.33M | 109K | -267K | -382.38%-4.57M | -21.29%-245K | -43.46%-307K |
| Operating expense | 316.19%1.9M | 6.58%891K | -77.39%2.4M | 387K | -22.67%1.56M | 457K | 836K | -13.49%10.63M | -63.76%2.02M | 61.38%3.43M |
| Selling and administrative expenses | 316.19%1.9M | 6.58%891K | -93.58%2.4M | --387K | -22.67%1.56M | --457K | --836K | 169.50%37.4M | -63.76%2.02M | 61.38%3.43M |
| -General and administrative expense | 316.19%1.9M | 6.58%891K | -93.58%2.4M | --387K | -22.67%1.56M | --457K | --836K | 169.50%37.4M | -63.76%2.02M | 61.38%3.43M |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,582.65%26.77M | ---- | ---- |
| Operating profit | -399.43%-1.74M | 30.28%-769K | 74.25%-3.92M | -680K | -27.69%-2.89M | -348K | -1.1M | -14.87%-15.2M | 60.78%-2.26M | -59.73%-3.73M |
| Net non-operating interest income (expenses) | -12.43%-380K | 7.51%-382K | 26.73%-1.51M | -381K | -110.61%-794K | -338K | -413K | -75.89%-2.07M | -8.33%-377K | -60.11%-293K |
| Non-operating interest expense | 12.43%380K | -7.51%382K | -26.73%1.51M | --381K | 110.61%794K | --338K | --413K | 75.89%2.07M | 8.33%377K | 60.11%293K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | 0 | 0 | 0 | 0 | |||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | -97.02%7K | -62.50%15K | -48.58M | -48.94M | -10.00%126K | 235K | 40K | 102.63%140K | 111.76%144K | |
| Income before tax | -368.07%-2.11M | 23.04%-1.14M | -212.77%-54.01M | -50M | -42.31%-3.56M | -451K | -1.48M | -19.84%-17.27M | 78.15%-2.5M | -58.32%-3.88M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -368.07%-2.11M | 23.04%-1.14M | -212.77%-54.01M | -50M | -42.31%-3.56M | -451K | -1.48M | -40.29%-17.27M | 72.58%-2.5M | -58.32%-3.88M |
| Net income continuous operations | -368.07%-2.11M | 23.04%-1.14M | -212.77%-54.01M | ---50M | -42.31%-3.56M | ---451K | ---1.48M | -40.29%-17.27M | 72.58%-2.5M | -58.32%-3.88M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -368.07%-2.11M | 23.04%-1.14M | -212.77%-54.01M | -50M | -42.31%-3.56M | -451K | -1.48M | -40.29%-17.27M | 72.58%-2.5M | -58.32%-3.88M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -368.07%-2.11M | 23.04%-1.14M | -212.77%-54.01M | -50M | -42.31%-3.56M | -451K | -1.48M | -40.29%-17.27M | 72.58%-2.5M | -58.32%-3.88M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -360.00%-0.0092 | 23.08%-0.005 | -641.07%-0.9456 | -0.8756 | -43.12%-0.0156 | -0.002 | -0.0065 | -117.01%-0.1276 | 5.22%-0.0109 | -5.00%-0.0168 |
| Diluted earnings per share | -360.00%-0.0092 | 23.08%-0.005 | 92.59%-0.9456 | -0.8756 | -43.12%-0.0156 | -0.002 | -0.0065 | -21,600.68%-12.76 | 5.22%-0.0109 | -5.00%-0.0168 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.